💉 Ketamine Therapy for Chronic Pain: What You Need to Know

Chronic pain affects an estimated 50 million Americans and is one of the leading causes of disability worldwide. For patients with conditions like complex regional pain syndrome (CRPS), fibromyalgia, neuropathic pain, and central sensitization syndromes, conventional pain management options — including opioids, nerve blocks, and physical therapy — often provide incomplete relief. Ketamine infusion therapy has become an increasingly important tool in the chronic pain treatment arsenal.

Unlike opioid medications, which carry significant risks of addiction, tolerance, and overdose, ketamine works through the NMDA receptor system to address the underlying neurological mechanisms that sustain chronic pain. Ketamine infusions for chronic pain are typically administered at higher doses and over longer durations than those used for depression, often lasting 4-8 hours per session compared to the standard 40-minute depression infusion.

Ketamine clinics specializing in chronic pain management offer individualized protocols tailored to specific pain conditions. CRPS patients, in particular, have shown remarkable responses to ketamine therapy, with some experiencing sustained pain relief that allows them to reduce or eliminate opioid medications. Many pain-focused ketamine programs work in conjunction with the patient's existing pain management team to provide comprehensive, multimodal care.

How Ketamine Works for Chronic Pain

Ketamine treats chronic pain primarily through NMDA receptor blockade, which interrupts a process called central sensitization — a condition in which the central nervous system amplifies pain signals, causing patients to experience heightened pain responses to stimuli that would not normally be painful. By blocking NMDA receptors, ketamine essentially "resets" these malfunctioning pain circuits and reduces the phenomenon known as "wind-up," where pain signals become progressively amplified.

Ketamine also reduces opioid tolerance through its NMDA antagonism, meaning patients on chronic opioid therapy may experience improved pain relief from their existing medications after ketamine treatment. Additionally, ketamine has anti-inflammatory properties mediated through its effects on cytokine production and microglial activation, which contribute to its pain-relieving effects. For conditions like CRPS, ketamine may also help normalize sympathetic nervous system dysfunction that drives the disease process.

Clinical Evidence

A landmark study by Sigtermans et al. (2009) demonstrated that a continuous ketamine infusion over 4 days produced sustained pain relief in CRPS patients lasting an average of 11 weeks after treatment. Multiple systematic reviews have confirmed ketamine's efficacy for neuropathic pain, CRPS, and fibromyalgia. For CRPS specifically, response rates of 60-80% have been reported in clinical series, with some patients achieving complete remission of symptoms. Ketamine infusions for pain are typically longer (4-8 hours) and may involve multi-day protocols compared to the shorter infusions used for mood disorders.

Who Is a Candidate?

Ideal candidates for ketamine pain therapy include patients diagnosed with CRPS (complex regional pain syndrome), fibromyalgia, neuropathic pain conditions (diabetic neuropathy, post-herpetic neuralgia, peripheral neuropathy), central sensitization syndromes, and chronic pain that has failed to respond to conventional treatments. Patients who are seeking to reduce opioid dependence or those who have developed opioid tolerance are also good candidates. Patients should have a confirmed chronic pain diagnosis from a pain specialist and have typically tried and failed multiple conventional pain management approaches.

Side Effects to Consider

Side effects during ketamine infusions for chronic pain may be more pronounced than in shorter depression infusions due to the longer treatment duration and potentially higher doses used. Common side effects include dissociation, vivid dreams or hallucinations, nausea (which can be managed with anti-emetics), dizziness, and temporary increases in blood pressure. Some patients experience fatigue or cognitive "fogginess" for 24 hours after longer infusions. Patients with chronic pain conditions are monitored throughout the extended infusion period, and doses are titrated to balance pain relief with tolerability.

Frequently Asked Questions

Common questions about ketamine therapy for chronic pain conditions including fibromyalgia, CRPS, and neuropathic pain.

Does ketamine work for chronic pain?

Yes, ketamine is an established treatment for several chronic pain conditions, particularly CRPS (complex regional pain syndrome), fibromyalgia, and neuropathic pain. It works by blocking NMDA receptors to interrupt central sensitization — the neurological process that amplifies and sustains chronic pain signals. Clinical evidence supports its use when other pain treatments have been insufficient.

How long does ketamine pain relief last?

The duration of pain relief from ketamine varies by condition and protocol. For CRPS, studies have shown sustained relief lasting an average of 11 weeks after a multi-day infusion series. For other chronic pain conditions, relief typically lasts 2-8 weeks. Maintenance infusions are usually needed to sustain benefits, with frequency determined by individual response.

Is ketamine better than opioids for chronic pain?

Ketamine and opioids work through different mechanisms and serve different roles. Ketamine addresses central sensitization (the underlying driver of many chronic pain conditions), while opioids primarily mask pain signals. Ketamine does not carry the risks of physical dependence, respiratory depression, or overdose associated with opioids. Many pain specialists use ketamine to help patients reduce or eliminate opioid use.

What types of pain does ketamine treat?

Ketamine is most effective for neuropathic pain conditions (CRPS, diabetic neuropathy, peripheral neuropathy), fibromyalgia, central sensitization syndromes, phantom limb pain, and some types of headache disorders. It is less effective for purely nociceptive pain (such as osteoarthritis). Your pain specialist can determine whether your specific pain condition is likely to respond to ketamine therapy.